Theriva Biologics (TOVX) announced the receipt of Scientific Advice from the Committee for Medicinal Products for Human Use ...

DECLARATION is a Phase 3, randomized, placebo-controlled clinical trial to evaluate the safety and efficacy of VYD2311 in the prevention of COVID ...

Background Hypertension is a major cause of premature death worldwide, controlled by only one in five adults. Two trials ...

EMA provided overall agreement with the proposed Phase 3 clinical trial of VCN-01 in combination with ...

Introduction Implementation of low-intensity, evidence-based psychological interventions can help meet the mental health and ...

Traditional Chinese medicine (TCM) pediatric tuina may be safe and effective as supplementary therapy in children with severe pneumonia.

The FDA is raising the bar for approval of CAR T-cell therapies in oncology. Under plans outlined by the FDA’s biologics chief Vinay Prasad, M.D., the agency will require developers of many CAR-Ts to ...

Introduction Nasogastric tubes (NGTs) are standard practice in the management of adhesive small bowel obstruction (ASBO). Their insertion can be associated with significant patient discomfort and ...

Theriva Biologics ( ($TOVX) ) just unveiled an update. On December 29, 2025, Theriva Biologics reported that it received positive Scientific ...

Self-hypnosis is an accessible, effective treatment for hot flashes, according to an expert. Gary Elkins, PhD, professor of ...

HHS Secretary Robert F. Kennedy Jr.s CDC just funneled a $1.6 million dollar grant to researchers to carry out an unethical and scientifically unjustified randomized clinical trial of the birth dose o ...

Gilead's ARTISTRY-2 trial shows BIC/LEN is non-inferior to Biktarvy in virologically suppressed adults with HIV, with no new safety signals. ARTISTRY-2's design involved a randomized, double-blind ...